Teradyne Reports Second Quarter 2011 Results

- Q2’11 revenue of $411 million, up 9% from Q1’11 and down 8% from Q2’10

- Q2'11 diluted non-GAAP income from continuing operations of $0.50 per share, up from $0.39 per share in Q1’11 and down from $0.69 per share in Q2'10; Q2’11 diluted GAAP income from continuing operations of $0.39 per share

- Q3’11 guidance: Revenue of $320 million to $340 million; Diluted non-GAAP income from continuing operations of $0.22 to $0.26 per share; Diluted GAAP income from continuing operations of $0.15 to $0.18 per share

NORTH READING, Mass.--()--Teradyne, Inc. (NYSE: TER) reported revenue of $411 million for the second quarter of 2011 of which $343 million was in Semiconductor Test and $68 million in Systems Test Group. On a non-GAAP basis, Teradyne’s income from continuing operations in the second quarter was $101.5 million, or $0.50 per diluted share, which excluded acquired intangible asset amortization, non-cash convertible debt interest and restructuring and other charges. GAAP income from continuing operations for the second quarter was $89.9 million, or $0.39 per diluted share.

Bookings in the second quarter of 2011 were $333 million of which $257 million were in Semiconductor Test and $76 million in the Systems Test Group.

"We delivered solid financial results in the second quarter marking the sixth quarter in a row of above model profitability," said Mike Bradley, Teradyne President and CEO. “We saw continued strength in Hard Disk Drive Test orders as we expand both the performance and customer base of our Neptune product line. While System on a Chip (SOC) test orders slowed substantially in the quarter, the wireless and media processor, power management, and imaging segments were the strongest, driven by both design wins and capacity expansions.”

"With the softening order rate in semiconductor test dictating lower shipments in the third quarter, we're pleased to see increasing HDD test shipments offset some of that decline. While delivering lower gross margins than our other businesses, HDD test is on track to deliver model profitability on record revenues this year.”

Guidance for the third quarter of 2011 is for revenue of $320 million to $340 million, with non-GAAP income from continuing operations per diluted share of $0.22 to $0.26 and GAAP income from continuing operations per diluted share of $0.15 to $0.18. Non-GAAP guidance excludes acquired intangible asset amortization, non-cash convertible debt interest and restructuring and other charges.

Webcast

A conference call to discuss the second quarter 2011 results, along with management's business outlook is scheduled at 10 a.m. EDT, Thursday, July 28. The call will be broadcast simultaneously over the Internet. Interested investors should access the webcast at www.teradyne.com and click on "Investors" at least five minutes before the call begins.

A replay will be available approximately two hours after the completion of the call. The replay number in the U.S. & Canada is 800-642-1687. The replay number outside the U.S. & Canada is 706-645-9291. The pass code for both numbers is 82250574. A replay will also be available on the Teradyne website at www.teradyne.com and by phone. The phone replay will be available through August 13, 2011.

Non-GAAP Results

In addition to disclosing results that are determined in accordance with GAAP, Teradyne also discloses non-GAAP results of operations that exclude certain income items and charges. These results are provided as a complement to results provided in accordance with GAAP. Non-GAAP income from operations and non-GAAP income from continuing operations exclude acquired intangible asset amortization, non-cash convertible debt interest, and restructuring and other, net. GAAP requires that these items be included in determining income from operations and income from continuing operations. Non-GAAP income from operations, non-GAAP income from continuing operations, non-GAAP income from operations and non-GAAP income from continuing operations as a percentage of revenue, and non-GAAP income from continuing operations per share are non-GAAP measures presented to provide meaningful supplemental information regarding Teradyne's baseline performance before gains, losses or other charges that may not be indicative of Teradyne’s current core business or future outlook. These non-GAAP measures are used to make operational decisions, to determine employee compensation, to forecast future operational results, and for comparison with Teradyne’s business plan, historical operating results and the operating results of Teradyne’s competitors. Non-GAAP diluted shares include the impact of Teradyne’s call option on its shares. Management believes each of these non-GAAP measures provides useful supplemental information for investors, allowing greater transparency to the information used by management in its operational decision making and in the review of Teradyne’s financial and operational performance, as well as facilitating meaningful comparisons of Teradyne’s results in the current period compared with those in prior and future periods. A reconciliation of each available GAAP to non-GAAP financial measure discussed in this press release is contained in the attached exhibits and on the Teradyne website at www.teradyne.com by clicking on "Investors" and then selecting the "GAAP to Non-GAAP Reconciliation" link. The presentation of non-GAAP measures is not meant to be considered in isolation, as a substitute for, or superior to, financial measures or information provided in accordance with GAAP.

About Teradyne

Teradyne (NYSE:TER) is the leading supplier of Automatic Test Equipment used to test complex electronics used in the consumer electronics, automotive, computing, telecommunications, and aerospace and defense industries. Teradyne had 2010 sales of $1.6 billion and employs about 2,900 people worldwide. For more information, visit www.teradyne.com. Teradyne(R) is a registered trademark of Teradyne, Inc. in the U.S. and other countries.

Safe Harbor Statement

This release contains forward-looking statements regarding future business prospects, Teradyne’s results of operations and market conditions. Such statements are based on the current assumptions and expectations of Teradyne’s management and are neither promises nor guarantees of future performance. You can identify these forward-looking statements based on the context of the statements and by the fact that they use words such as “will,” “anticipate,” “expect,” “project,” “intend,” “plan,” “believe,” “target” and other words and terms of similar meaning in connection with any discussion of future operating or financial performance. There can be no assurance that management’s estimates of Teradyne’s future results or other forward looking statements will be achieved. Important factors that could cause actual results to differ materially from those presently expected include: conditions affecting the markets in which Teradyne operates; decreased or delayed product demand; increased competition in certain markets resulting from the merger of Advantest and Verigy; and other events, factors and risks disclosed in filings with the SEC, including, but not limited to, the “Risk Factors” section of Teradyne’s Annual Report on Form 10-K for the fiscal year ended December 31, 2010 and Quarterly Report on Form 10-Q for the period ended April 3, 2011. The forward-looking statements provided by Teradyne in this press release represent management’s views as of the date of this release. Teradyne anticipates that subsequent events and developments may cause management's views to change. However, while Teradyne may elect to update these forward-looking statements at some point in the future, Teradyne specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing Teradyne's views as of any date subsequent to the date of this release.

         
TERADYNE, INC. REPORT FOR SECOND FISCAL QUARTER OF 2011
                     
CONDENSED CONSOLIDATED OPERATING STATEMENTS
(In thousands, except per share amounts)                    
 
Quarter Ended Six Months Ended

July 3, 2011

April 3, 2011 July 4, 2010 July 3, 2011 July 4, 2010
 
Net Revenues $ 410,519 $ 377,161 $ 445,271 $ 787,680 $ 764,609
 
Cost of Revenues (1)   195,433     184,752     194,369     380,185     343,831  
 
Gross Profit 215,086 192,409 250,902 407,495 420,778
 
Operating Expenses:
Engineering and Development 47,393 47,977 49,341 95,370 97,278
Selling and Administrative 57,481 58,229 57,730 115,710 112,417
Acquired Intangible Asset Amortization 7,291 7,291 7,313 14,582 14,668
Restructuring and Other, net (2)   1,279     413     371     1,692     1,274  
Operating Expenses 113,444 113,910 114,755 227,354 225,637
 
Income from Operations 101,642 78,499 136,147 180,141 195,141
 
Interest & Other (3)   (3,913 )   (4,889 )   (4,074 )   (8,802 )   (9,139 )
 
Income from Continuing Operations Before Income Taxes 97,729 73,610 132,073 171,339 186,002
Income Tax Provision   7,839     5,486     9,543     13,325     14,373  
Income from Continuing Operations 89,890 68,124 122,530 158,014 171,629
 
Income (Loss) from Discontinued Operations Before Income Taxes (4) - 1,278 (381 ) 1,278 620
Income Tax Benefit   -     (267 )   -     (267 )   -  
Income (Loss) from Discontinued Operations - 1,545 (381 ) 1,545 620
 

(Loss) Gain on Disposal of Discontinued Operations (net of income tax provision
of $0, $4,578, $0, $4,578, and $0, respectively)

  (832 )   25,203     -     24,371     -  
 
Net Income $ 89,058   $ 94,872   $ 122,149   $ 183,930   $ 172,249  
 

Income per Common Share from Continuing Operations:

Basic $ 0.48   $ 0.37   $ 0.68   $ 0.85   $ 0.97  
Diluted $ 0.39   $ 0.29   $ 0.55   $ 0.68   $ 0.79  
 

Net Income per Common Share:

Basic $ 0.48   $ 0.51   $ 0.68   $ 0.99   $ 0.97  
Diluted $ 0.39   $ 0.41   $ 0.55   $ 0.80   $ 0.79  
 
 
Weighted Average Common Shares - Basic   185,367     184,720     179,990     185,044     178,429  
 
 
Weighted Average Common Shares - Diluted (5)   230,452     232,080     231,541     231,266     228,909  
 
Net Orders $ 333,170   $ 435,077   $ 505,755   $ 768,247   $ 1,028,567  
 
 
(1) Cost of Revenues includes: Quarter Ended Six Months Ended
July 3, 2011 April 3, 2011 July 4, 2010 July 3, 2011 July 4, 2010
Sale of Previously Written Down Inventory $ (764 ) $ (3,022 ) $ (5,232 ) $ (3,786 ) $ (5,232 )
Provision for Excess and Obsolete Inventory   1,716     4,627     276     6,343     1,454  
$ 952   $ 1,605   $ (4,956 ) $ 2,557   $ (3,778 )
 
 
(2) Restructuring and Other, net consists of: Quarter Ended Six Months Ended
July 3, 2011 April 3, 2011 July 4, 2010 July 3, 2011 July 4, 2010
Employee Severance $ 344 $ 844 $ 371 $ 1,188 $ 1,274
Non-U.S. Pension Settlement 935 - - 935 -
Facility Related   -     (431 )   -     (431 )   -  
$ 1,279   $ 413  

$

371   $ 1,692   $ 1,274  
 
 
(3) Interest & Other includes: Quarter Ended Six Months Ended
July 3, 2011 April 3, 2011 July 4, 2010 July 3, 2011 July 4, 2010
Non-Cash Convertible Debt Interest $ 2,957 $ 2,858

$

2,580 $ 5,815 $ 5,074
 

(4) On March 21, 2011, Teradyne completed the sale of its Diagnostic Solutions business unit to SPX Corporation for a gain of $24.4 million.
The results for the discontinued business unit have been included within discontinued operations for all periods presented.

 
(5) Under GAAP, when calculating diluted earnings per share, convertible debt must be assumed to have converted if the effect on EPS would be dilutive. Diluted shares assume the conversion of the convertible debt as the effect would be dilutive. Accordingly, for the quarters ended July 3, 2011, April 3, 2011, and July 4, 2010, 22.7 million, 23.4 million and 34.7 million shares, respectively, have been included in diluted shares and net interest expense of $0, $0 and $4.4 million, respectively, has been added back to income from continuing operations and net income for the diluted earnings per share calculations. For the six months ended July 3, 2011 and July 4, 2010, 23.0 million and 34.7 million shares, respectively, have been included in diluted shares and net interest expense of $0 and $8.8 million, respectively, has been added back to income from continuing operations and net income for the diluted earnings per share calculations.
 

   
CONDENSED CONSOLIDATED BALANCE SHEETS (In thousands)        
 
July 3, 2011 December 31, 2010
 
Assets
Cash and Cash Equivalents $ 455,398 $ 397,737
Marketable Securities 453,942 409,061
Accounts Receivable 207,823 168,756
Inventories 141,518 116,841
Deferred Tax Assets 22,801 22,730
Prepayments and Other Current Assets 61,946 52,780
Current Assets from Discontinued Operations (1)   -     8,713
Total Current Assets 1,343,428 1,176,618
 
Net Property, Plant and Equipment 233,432 231,108
Long-Term Marketable Securities 281,978 248,696
Retirement Plan Assets 14,456 13,981
Intangible Assets 108,357 122,941
Other Assets 16,644 16,542
Long-Term Assets from Discontinued Operations (1)   -   469
Total Assets $ 1,998,295 $ 1,810,355
 
Liabilities
Accounts Payable $ 106,993 $ 81,142
Accrued Employees' Compensation and Withholdings 75,018 105,374
Deferred Revenue and Customer Advances 98,723 105,568
Other Accrued Liabilities 59,889 57,145
Accrued Income Taxes 9,888 8,465
Current Debt 2,475 2,450
Current Liabilities from Discontinued Operations (1)   -   3,560
Total Current Liabilities 352,986 363,704
 
Long-Term Deferred Revenue and Customer Advances 50,064 71,558
Retirement Plan Liabilities 77,154 72,071
Deferred Tax Liabilities 9,973 9,849
Other Long-Term Liabilities 19,359 19,448
Long-Term Debt 154,821 150,182
Long-Term Liabilities from Discontinued Operations (1)   -     1,355
Total Liabilities 664,357 688,167
 
Shareholders' Equity 1,333,938 1,122,188
   
Total Liabilities and Shareholders' Equity $ 1,998,295 $ 1,810,355
 
             
 
(1) On March 21, 2011, Teradyne completed the sale of its Diagnostic Solutions business unit to SPX Corporation. The assets and liabilities of the discontinued business unit have been included within discontinued operations at December 31, 2010.
 
 
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (In thousands)
         
Quarter Ended Six Months Ended
July 3, 2011 July 4, 2010   July 3, 2011 July 4, 2010
Cash flows from operating activities:
Net income $ 89,058 $ 122,149 $ 183,930 $ 172,249
Less: (Loss) income from discontinued operations - (381 ) 1,545 620
Less: (Loss) gain on disposal of discontinued operations   (832 )   -     24,371     -  
Income from continuing operations 89,890 122,530 158,014 171,629

Adjustments to reconcile income from continuing operations to net
cash provided by operating activities:

Depreciation 12,588 13,244 25,645 26,403
Amortization 12,849 11,173 25,291 23,105
Stock-based compensation 7,218 7,168 14,682 15,141
Provision for excess and obsolete inventory 1,716 276 6,343 1,454
Tax benefit related to stock options and restricted stock units (3,717 ) - (3,717 ) -
Other 804 475 1,424 1,659
Changes in operating assets and liabilities, net of businesses sold:
Accounts receivable (21,569 ) (70,041 ) (39,067 ) (123,184 )
Inventories (4,297 ) 9,337 (15,006 ) 24,231
Other assets (7,807 ) (4,517 ) (10,348 ) 15,544
Deferred revenue and customer advances (3,786 ) (27,537 ) (28,339 ) (62,901 )
Accounts payable and accrued expenses 16,739 51,393 (9,279 ) 52,377
Retirement plan contributions (4,069 ) (18,017 ) (5,241 ) (24,677 )
Accrued income taxes   5,406     11,346     5,406     11,346  
Net cash provided by continuing operations 101,965 106,830 125,808 132,127
Net cash provided by (used for) discontinued operations   -     1,062     (4,225 )   1,850  
Net cash provided by operating activities 101,965 107,892 121,583 133,977
 
Cash flows from investing activities:
Purchases of property, plant and equipment (22,336 ) (18,119 ) (44,467 ) (35,706 )
Purchases of available-for-sale marketable securities (287,252 ) (128,421 ) (498,541 ) (223,820 )
Proceeds from sales of available-for-sale marketable securities 232,029 40,197 420,477 47,267
Proceeds from sales of trading marketable securities - 23,550 - 23,700
Proceeds from life insurance   -     1,091     -     1,091  
Net cash used for continuing operations (77,559 ) (81,702 ) (122,531 ) (187,468 )
Net cash provided by discontinued operations   32     -     39,062     -  
Net cash used by investing activities (77,527 ) (81,702 ) (83,469 ) (187,468 )
 
Cash flows from financing activities:
Issuance of common stock 6,976 35,794 17,052 41,873
Tax benefit related to stock options and restricted stock units 3,717 - 3,717 -
Payments of long-term debt   -       -     (1,222 )   (1,123 )
Net cash provided by continuing operations 10,693 35,794 19,547 40,750
Net cash provided by discontinued operations   -     -     -     -  
Net cash provided by financing activities 10,693 35,794 19,547 40,750
 
Increase (decrease) in cash and cash equivalents 35,131 61,984 57,661 (12,741 )
Cash and cash equivalents at beginning of period   420,267     342,012     397,737     416,737  
Cash and cash equivalents at end of period $ 455,398   $ 403,996   $ 455,398   $ 403,996  
 

                                           
GAAP to Non-GAAP Earnings Reconciliation
 
(In millions, except per share amounts)
Quarter Ended
July 3, 2011  

% of Net
Revenues

        April 3, 2011      

% of Net
Revenues

 

    July 4, 2010      

% of Net
Revenues

       
 
Net Revenues $ 410.5 $ 377.2 $ 445.3
 
Income from Operations - GAAP $ 101.6 24.8 % $ 78.5 20.8 % $ 136.1 30.6 %

Acquired intangible
asset amortization

7.3 1.8 % 7.3 1.9 % 7.3 1.6 %

Restructuring and
other, net (1)

  1.3   0.3 %   0.4   0.1 %   0.4   0.1 %

Income from
Operations - non-GAAP

$ 110.2   26.8 % $ 86.2   22.9 % $ 143.8   32.3 %
 

Income
per Common
Share
from Continuing
Operations

Income
per Common
Share
from Continuing
Operations

 

Income
per Common Share
from Continuing
Operations

July 3, 2011  

% of Net
Revenues

 

Basic

  Diluted April 3, 2011      

% of Net
Revenues

  Basic   Diluted July 4, 2010      

% of Net
Revenues

  Basic   Diluted
Income from Continuing Operations - GAAP $ 89.9 21.9 % $ 0.48 $ 0.39 $ 68.1 18.1 % $ 0.37 $ 0.29 $ 122.5 27.5 % $ 0.68 0.55
Acquired intangible asset amortization 7.3 1.8 % 0.04 0.04 7.3 1.9 % 0.04 0.03 7.3 1.6 % 0.04 0.04
Restructuring and other, net (1) 1.3 0.3 % 0.01 0.01 0.4 0.1 % - - 0.4 0.1 % - -
Convertible share adjustment (2) - - - 0.05 - - - 0.06 - - - 0.09
Interest and other (3)   3.0   0.7 %   0.02   0.01   2.9   0.8 %   0.02   0.01   2.6   0.6 %   0.01   0.01
Income from Continuing Operations - non-GAAP $ 101.5   24.7 % $ 0.55 $ 0.50 $ 78.7   20.9 % $ 0.43 $ 0.39 $ 132.8   29.8 % $ 0.74 $ 0.69
 
GAAP and Non-GAAP Weighted Average Common Shares - Basic 185.4 184.7 180.0
GAAP Weighted Average Common Shares - Diluted 230.5 232.1 231.5

Exclude dilutive
shares from
convertible note

  (22.7 )   (23.4 )   (34.7 )
Non-GAAP Weighted Average Common Shares - Diluted (2)   207.8     208.7     196.8  
 
 
(1) Restructuring and other, net consists of (in millions):
Quarter Ended
July 3, 2011 April 3, 2011 July 4, 2010
Employee Severance $ 0.3 $ 0.8 $ 0.4
Non-U.S. Pension Settlement 0.9 - -
Facility Related   -     (0.4 )   -  
$ 1.3   $ 0.4   $ 0.4  
 
(2) For the quarters ended July 3, 2011, April 3, 2011 and July 4, 2010, the calculation of non-GAAP diluted earnings per share gives benefit to the Company's call option on its stock for 34.7 million shares at $5.48. As a result, 17.9 million, 18.8 million and 11.2 million shares, respectively, have been included in non-GAAP diluted shares and net interest expense of $2.4 million has been added back to non-GAAP net income for the non-GAAP diluted earnings per share calculation.
 
 
(3) For the quarters ended July 3, 2011, April 3, 2011 and July 4, 2010, Interest and Other included non-cash convertible debt interest.
 

  Six Months Ended
July 3, 2011          

% of Net
Revenues

          July 4, 2010      

% of Net
Revenues

       
 
Net Revenues $ 787.7 $ 764.6
 
Income from Operations - GAAP $ 180.1 22.9 % $ 195.1 25.5 %
Acquired intangible asset amortization 14.6 1.9 % 14.7 1.9 %
Restructuring and other, net (1)   1.7     0.2 %   1.3   0.2 %
Income from Operations - non-GAAP $ 196.4     24.9 % $ 211.1   27.6 %
 

 

Income
per Common Share
from Continuing
Operations

Income
per Common Share
from Continuing
Operations

July 3, 2011

% of Net
Revenues

Basic       Diluted July 4, 2010

% of Net
Revenues

  Basic Diluted
Income from Continuing Operations - GAAP $ 158.0 20.1 % $ 0.85 $ 0.68 $ 171.6 22.4 % $ 0.97 $ 0.79
Acquired intangible asset amortization 14.6 1.9 % $ 0.08 0.07 14.7 1.9 % 0.08 0.08
Interest and other (2) 5.8 0.7 % $ 0.03 0.03 5.1 0.7 % 0.03 0.03
Restructuring and other, net (1) 1.7 0.2 % $ 0.01 0.01 1.3 0.2 % 0.01 0.01
Convertible share adjustment (3)   -     -   $ -   0.10   -   -     -   0.11
Income from Continuing Operations - non-GAAP $ 180.1     22.9 % $ 0.97 $ 0.89 $ 192.7   25.2 % $ 1.08 $ 1.02
 
GAAP and Non-GAAP Weighted Average Common Shares - Basic 185.0 178.4
 
GAAP Weighted Average Common Shares - Diluted 231.3 228.9
Exclude dilutive shares from convertible note   (23.0 )   (34.7 )
Non-GAAP Weighted Average Common Shares - Diluted (3)   208.3     194.2  
 
(1) Restructuring and other, net consists of:
Six Months Ended
July 3, 2011 July 4, 2010
Employee Severance $ 1.2 $ 1.3
Non-U.S. Pension Settlement 0.9 -
Facility Related   (0.4 )   -  
$ 1.7   $ 1.3  
 
(2)For the six months ended July 3, 2011 and July 4, 2010, Interest and Other included non-cash convertible debt interest.
 
(3)For the six months ended July 3, 2011 and July 4, 2010, the calculation of non-GAAP diluted earnings per share gives benefit to the Company's call option on its stock for 34.7 million shares at $5.48. As a result, 23.0 million and 10.2 million shares, respectively, have been included in non-GAAP diluted shares and net interest expense of approximately $4.8 million has been added back to non-GAAP net income for the non-GAAP diluted earnings per share calculation.
 
 
GAAP to Non-GAAP Reconciliation of Third Quarter 2011 guidance:
 
GAAP and Non-GAAP third quarter revenue guidance: $320 million to $340 million
GAAP income from continued operations per diluted share $ 0.15 $ 0.18
Exclude acquired intangible asset amortization $ 0.03 $ 0.03
Exclude non-cash convertible debt interest $ 0.01 $ 0.01
Exclude dilutive shares from convertible note $ 0.03   $ 0.04  
Non-GAAP income from continuing operations per diluted share $ 0.22 $ 0.26
 

Contacts

Teradyne, Inc.
Andrew Blanchard, 978-370-2425
Investor Relations
investorrelations@teradyne.com

Release Summary

Teradyne, Inc. (NYSE: TER) reported revenue of $411 million for the second quarter of 2011 of which $343 million was in Semiconductor Test and $68 million in Systems Test Group.

Contacts

Teradyne, Inc.
Andrew Blanchard, 978-370-2425
Investor Relations
investorrelations@teradyne.com